Yu-Shan Lin

629 total citations
31 papers, 490 citations indexed

About

Yu-Shan Lin is a scholar working on Molecular Biology, Pharmacology and Oncology. According to data from OpenAlex, Yu-Shan Lin has authored 31 papers receiving a total of 490 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 6 papers in Pharmacology and 5 papers in Oncology. Recurrent topics in Yu-Shan Lin's work include Bioactive Compounds and Antitumor Agents (4 papers), Natural product bioactivities and synthesis (3 papers) and Cloud Computing and Resource Management (3 papers). Yu-Shan Lin is often cited by papers focused on Bioactive Compounds and Antitumor Agents (4 papers), Natural product bioactivities and synthesis (3 papers) and Cloud Computing and Resource Management (3 papers). Yu-Shan Lin collaborates with scholars based in China, Taiwan and Hong Kong. Yu-Shan Lin's co-authors include Sibao Chen, William Tai, Shyi‐Neng Lou, Chi‐Tang Ho, Daniel Kam‐Wah Mok, Ching‐Ping Tseng, Yi‐Wen Liu, Chi‐Sing Lee, Yi-Pei Chen and Chung‐Yi Chen and has published in prestigious journals such as PLoS ONE, Journal of Agricultural and Food Chemistry and Food Chemistry.

In The Last Decade

Yu-Shan Lin

30 papers receiving 474 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yu-Shan Lin China 13 204 94 86 64 62 31 490
Bhupender Sharma India 7 318 1.6× 64 0.7× 83 1.0× 55 0.9× 59 1.0× 18 633
Vinay Bharadwaj Tatipamula India 14 223 1.1× 134 1.4× 127 1.5× 44 0.7× 60 1.0× 58 599
Islam Rady United States 9 220 1.1× 216 2.3× 85 1.0× 73 1.1× 49 0.8× 15 715
Duc Dat Le South Korea 15 355 1.7× 80 0.9× 179 2.1× 67 1.0× 59 1.0× 54 604
Eui‐Baek Byun South Korea 15 220 1.1× 65 0.7× 96 1.1× 89 1.4× 28 0.5× 39 528
Hyun Gyu Choi South Korea 16 256 1.3× 133 1.4× 142 1.7× 51 0.8× 35 0.6× 37 711
Yu‐Chi Tsai Taiwan 13 208 1.0× 72 0.8× 125 1.5× 34 0.5× 98 1.6× 45 600
Khaled Y. Orabi Kuwait 15 326 1.6× 146 1.6× 147 1.7× 36 0.6× 105 1.7× 40 678
Herbert Boechzelt Austria 11 262 1.3× 63 0.7× 69 0.8× 93 1.5× 27 0.4× 15 563

Countries citing papers authored by Yu-Shan Lin

Since Specialization
Citations

This map shows the geographic impact of Yu-Shan Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu-Shan Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu-Shan Lin more than expected).

Fields of papers citing papers by Yu-Shan Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu-Shan Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu-Shan Lin. The network helps show where Yu-Shan Lin may publish in the future.

Co-authorship network of co-authors of Yu-Shan Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Yu-Shan Lin. A scholar is included among the top collaborators of Yu-Shan Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu-Shan Lin. Yu-Shan Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
3.
Kao, C. J., et al.. (2024). Investigations of In2O3 Added SiC Semiconductive Thin Films and Manufacture of a Heterojunction Diode. Nanomaterials. 14(10). 881–881. 1 indexed citations
4.
Lin, Yu-Shan, Zhiwei Sun, Lisha Shen, et al.. (2024). Arnicolide D induces endoplasmic reticulum stress-mediated oncosis via ATF4 and CHOP in hepatocellular carcinoma cells. Cell Death Discovery. 10(1). 134–134. 13 indexed citations
5.
Chen, Jiawen, Rui‐Hong Gong, Yu-Shan Lin, et al.. (2024). Identification of a PANoptosis-related prognostic model in triple-negative breast cancer, from risk assessment, immunotherapy, to personalized treatment. Heliyon. 10(19). e38732–e38732. 1 indexed citations
6.
Lin, Yu-Shan, Herman W. Barkema, Yue Wang, et al.. (2023). Comparative Genomic Analyses of Lactococcus garvieae Isolated from Bovine Mastitis in China. Microbiology Spectrum. 11(3). e0299522–e0299522. 7 indexed citations
7.
Shen, Lisha, et al.. (2023). In Vitro and In Vivo Anti-Cancer Activity of Lasiokaurin in a Triple-Negative Breast Cancer Model. Molecules. 28(23). 7701–7701. 2 indexed citations
8.
Lin, Yu-Shan, et al.. (2023). Controlled Synthesis and Enhanced Gas Sensing Performance of Zinc-Doped Indium Oxide Nanowires. Nanomaterials. 13(7). 1170–1170. 5 indexed citations
9.
Barkema, Herman W., Yu-Shan Lin, Zhaoju Deng, et al.. (2023). Comparative genomic analyses of Klebsiella pneumoniae K57 capsule serotypes isolated from bovine mastitis in China. Journal of Dairy Science. 107(5). 3114–3126. 10 indexed citations
10.
Lin, Yu-Shan, et al.. (2023). Reversion of chemoresistance by endocannabinoid-induced ER stress and autophagy activation in ovarian cancer.. PubMed. 13(9). 4163–4178. 8 indexed citations
11.
Zhao, Wenpeng, Zhaoju Deng, Herman W. Barkema, et al.. (2022). Nrf2 and NF-κB/NLRP3 inflammasome pathways are involved in Prototheca bovis infections of mouse mammary gland tissue and mammary epithelial cells. Free Radical Biology and Medicine. 184. 148–157. 14 indexed citations
12.
Liu, Yang, Yu-Shan Lin, Yue Wang, et al.. (2022). Mycoplasma bovis inhibits autophagy in bovine mammary epithelial cells via a PTEN/PI3K-Akt-mTOR-dependent pathway. Frontiers in Microbiology. 13. 935547–935547. 14 indexed citations
13.
Zhao, Wenpeng, Herman W. Barkema, Xiaochen Xie, et al.. (2022). Prototheca bovis induces autophagy in bovine mammary epithelial cells via the HIF-1α and AMPKα/ULK1 pathway. Frontiers in Immunology. 13. 934819–934819. 6 indexed citations
14.
Lin, Yu-Shan, et al.. (2020). <p>Brevilin A, a Natural Sesquiterpene Lactone Inhibited the Growth of Triple-Negative Breast Cancer Cells via Akt/mTOR and STAT3 Signaling Pathways</p>. OncoTargets and Therapy. Volume 13. 5363–5373. 23 indexed citations
15.
Chan, Brandon, Wing‐Yan Wong, Tsz-Wing Leung, et al.. (2020). Anti-cancer Activity of Centipeda minima Extract in Triple Negative Breast Cancer via Inhibition of AKT, NF-κB, and STAT3 Signaling Pathways. Frontiers in Oncology. 10. 491–491. 39 indexed citations
16.
Lin, Yu-Shan, et al.. (2019). MgCrab. Proceedings of the VLDB Endowment. 12(5). 597–610. 11 indexed citations
17.
Liu, Rui, et al.. (2019). Brevilin A Induces Cell Cycle Arrest and Apoptosis in Nasopharyngeal Carcinoma. Frontiers in Pharmacology. 10. 594–594. 36 indexed citations
18.
Tseng, Shih-Pang, et al.. (2018). Health Care Spoken Dialogue System for Diagnostic Reasoning and Medical Product Recommendation. 242. 1–4. 4 indexed citations
19.
Wu, Shan-Hung, et al.. (2016). T-Part. 1553–1565. 7 indexed citations
20.
Lou, Shyi‐Neng, et al.. (2014). Soluble and insoluble phenolic compounds and antioxidant activity of immature calamondin affected by solvents and heat treatment. Food Chemistry. 161. 246–253. 71 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026